Funder: National Institutes of Health
Due Dates: April 4, 2025 | October 3, 2025 | December 9, 2025 (final deadline)
Funding Amounts: Up to $150,000 in direct costs per year, for up to 2 years; total program funding estimated at $150,000 per award.
Summary: Supports revision applications to active NCI R01 grants to incorporate new NCI IMAT-developed technologies and accelerate cancer research progress.
Key Information: Only current NCI R01 awardees with at least one year remaining are eligible; technology must be IMAT-supported and not developed by the parent R01 PI.